FeesSafety
Pluang+

Amplia gets ethics approval for ACCENT-Mini trial testing narmafotinib in pancreatic cancer

Company Fundamentals
19 Nov 2026, 15:45 WIB
GlobeNewsWire
View Source
Bullish
Amplia gets ethics approval for ACCENT-Mini trial testing narmafotinib in pancreatic cancer

Amplia Therapeutics has received ethics approval to start its ACCENT-Mini clinical trial, which will test daily doses of narmafotinib combined with chemotherapy in metastatic pancreatic cancer patients. This trial builds on positive results from the earlier ACCENT study, which showed improved survival and response rates with narmafotinib plus chemotherapy. Data from ACCENT-Mini expected in early 2027 will support Amplia's FDA submission for further studies. The trial is a key step in developing narmafotinib as a treatment option for difficult cancers resistant to current therapies.

Amplia Therapeutics' ACCENT-Mini trial is the story's subject, here is Pluang's health sector snapshot as of Nov 19, 2026 20:14 WIB: Of 150 priced US health stocks, 77 rose and 66 fell. Relay Therapeutics Inc. (RLAY) rose 2.60% to USD 16.94 with a typical hold time of 40 days. Natera Inc. (NTRA) increased 2.41% to USD 296.48, held typically for 11 days. Elanco Animal Health (ELAN) gained 2.06% to USD 27.25 with a 20-day hold time.

More News

Philips launches Advanced Image Insights, a cloud AI tool to streamline radiology workflows and reporting.

Philips launches Advanced Image Insights, a cloud AI tool to streamline radiology workflows and reporting.

Philips introduced Advanced Image Insights, a cloud-based solution that integrates advanced visualization and AI applications into radiology workflows. This platform connects image analysis with interactive reporting, helping radiologists manage comp...

Market News
Bullish
50 minutes ago
Bojangles boosts promotional menu capacity 8X and cuts shortages by 1,000 weekly with Armada's supply chain platform

Bojangles boosts promotional menu capacity 8X and cuts shortages by 1,000 weekly with Armada's supply chain platform

Bojangles expanded its limited-time offers from 3 to 26 per year using Armada's PRO platform, improving supply chain visibility and coordination without adding staff. This led to a reduction of 1,000 weekly shortages and nearly perfect fill rates dur...

Market News
Bullish
50 minutes ago
Disney shows stronger stability and upside than Nvidia despite both being cheap stocks.

Disney shows stronger stability and upside than Nvidia despite both being cheap stocks.

Disney and Nvidia both reported solid quarterly results and trade at about 16 times this year's earnings, making them historically cheap. Disney's stock is up 8% this year with a smooth CEO transition, while Nvidia's stock has slid 19% amid CEO scand...

Market News
Neutral
1 hour ago
Financial sector ETF XLF underperforms despite rising rates; history suggests potential for gains ahead.

Financial sector ETF XLF underperforms despite rising rates; history suggests potential for gains ahead.

The State Street Financial Select Sector SPDR ETF (XLF), a major financial sector fund, has underperformed this year despite a rising interest rate environment that typically benefits financial stocks. With the Federal Reserve expected to raise rates...

Bullish
1 hour ago
Bloom Energy posts strong Q3 growth but stock drops amid AI spending uncertainty

Bloom Energy posts strong Q3 growth but stock drops amid AI spending uncertainty

Bloom Energy reported a robust third quarter with revenue up 138% year-over-year to $1.24 billion and operating income rising sharply to $225 million. Despite this growth and improved profitability, the stock has fallen over 40% from its highs due to...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App